The results indicated that ASTN modulates intrahepatic immunity and reduces hepatocyte death and the expression of proinflammatory genes, ECM genes, oxidative stress-associated proteins, and bFGF in the fatty liver to ameliorate NASH progression. This evidence concerns the gene ASTN1 and metabolic dysfunction-associated steatohepatitis.